HYBRID EVENT: You can participate in person at London, UK from your home or work.

2nd Edition of International Conference on Gastroenterology

September 24-26, 2026, London,UK

September 24 -26, 2026 | London, UK

Gastrinoma

Gastrinoma

Gastrinoma is a rare type of tumor that originates in the cells of the stomach and small intestine. It is also known as a gastric neuroendocrine tumor (GNET). Gastrinomas are caused by the overproduction of the hormone gastrin. Gastrin is a hormone that is produced in the stomach and stimulates the production of acid, which helps to break down food. When too much of this hormone is produced, it can lead to an increase in the production of acid in the stomach, resulting in a condition known as Zollinger-Ellison Syndrome. Symptoms of gastrinoma may include abdominal pain, nausea, vomiting, diarrhea, and weight loss. Other symptoms may include steatorrhea, which is the presence of fatty stools, and jaundice. In some cases, patients may also experience flushing of the skin, severe headaches, and an enlarged liver. Treatment of gastrinoma typically involves surgery to remove the tumor and any associated tissue. Depending on the size and location of the tumor, chemotherapy, radiation therapy, and/or targeted drug therapy may be used to destroy the tumor or to shrink it. In some cases, medications may be used to block the production of gastrin or to control the symptoms of the condition. Gastrinoma is a rare condition, and it is important to seek medical attention if any of the above symptoms are present. Early diagnosis and treatment is key to managing the condition and preventing any complications that may arise. If left untreated, the condition can cause more serious health problems, including ulcers and bleeding in the digestive tract.

Submit your abstract Today

Watsapp